Active Lungs & Breathing NIHR-supported project Digestion, Kidneys & Other Organs

GSK / Southampton Collaborative Lung Fibrosis Project 1

Funder NIHR (part of DHSC)
Recipient organisation NIHR Southampton Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Mar 2025 — Mar 2027

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Mark Jones (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Skyhawk Therapeutics / Southampton Fibrosis Research Collaboration Project 1
Computer-aided CT imaging and integration with molecular endotyping to stratify fibrotic lung disease
Mis-programming of mesenchymal progenitor cells in human lung fibrosis.
HORIZON - A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults with Pre-Cirrhotic Non-Alcoholic Steatohepatitis
MICA: Molecular drivers of fibrosis at the hepatic epithelial-mesenchymal barrier

Original classification

Respiratory and Allergy (RA)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.